These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32129968)

  • 1. Melasma’s Impact on Quality of Life.
    Kagha K; Fabi S; Goldman MP
    J Drugs Dermatol; 2020 Feb; 19(2):184-187. PubMed ID: 32129968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Therapeutic Use of Antioxidants for Melasma.
    Babbush KM; Babbush RA; Khachemoune A
    J Drugs Dermatol; 2020 Aug; 19(8):788-792. PubMed ID: 32845595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melasma and assessment of the quality of life in Brazilian women.
    Ikino JK; Nunes DH; Silva VP; Fröde TS; Sens MM
    An Bras Dermatol; 2015; 90(2):196-200. PubMed ID: 25830989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies.
    Shenoy A; Madan R
    J Drugs Dermatol; 2020 Aug; 19(8):763-768. PubMed ID: 32845587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa.
    Mpofana N; Paulse M; Gqaleni N; Makgobole MU; Pillay P; Hussein A; Dlova NC
    Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
    Lima EVA; Lima MMDA; Paixão MP; Miot HA
    BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melasma: a clinical and epidemiological review.
    Handel AC; Miot LD; Miot HA
    An Bras Dermatol; 2014; 89(5):771-82. PubMed ID: 25184917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a health-related quality of life instrument for women with melasma.
    Balkrishnan R; McMichael AJ; Camacho FT; Saltzberg F; Housman TS; Grummer S; Feldman SR; Chren MM
    Br J Dermatol; 2003 Sep; 149(3):572-7. PubMed ID: 14510991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melasma in Latin Americans.
    Perez M; Luke J; Rossi A
    J Drugs Dermatol; 2011 May; 10(5):517-23. PubMed ID: 21533299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aggressive face of melasma: unveiling the influence of upper lip pigmentation on social perception.
    Jankowski M; Jasiński K; Płocka M; Goroncy A
    Postepy Dermatol Alergol; 2024 Apr; 41(2):173-180. PubMed ID: 38784936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous Pathology of Melasma and Its Clinical Implications.
    Kwon SH; Hwang YJ; Lee SK; Park KC
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.
    Zhu Y; Zeng X; Ying J; Cai Y; Qiu Y; Xiang W
    PLoS One; 2022; 17(1):e0262833. PubMed ID: 35085327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo.
    Amatya B; Pokhrel DB
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):114-118. PubMed ID: 32632057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melasma: a comprehensive update: part I.
    Sheth VM; Pandya AG
    J Am Acad Dermatol; 2011 Oct; 65(4):689-697. PubMed ID: 21920241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language.
    Dominguez AR; Balkrishnan R; Ellzey AR; Pandya AG
    J Am Acad Dermatol; 2006 Jul; 55(1):59-66. PubMed ID: 16781293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melasma and its impact on health-related quality of life in Hispanic women.
    Pawaskar MD; Parikh P; Markowski T; McMichael AJ; Feldman SR; Balkrishnan R
    J Dermatolog Treat; 2007; 18(1):5-9. PubMed ID: 17365259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Management of Melasma on Skin Types V and VI Using Light Emitting Diode Treatment.
    Mpofana N; Abrahamse H
    Photomed Laser Surg; 2018 Oct; 36(10):522-529. PubMed ID: 30227084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.